TXMD - Rasio utang marang kapitalisasi buku therapeuticsmd.com

Steady demand for women's health products provides TherapeuticsMD, Inc. (TXMD) with predictable revenue. The history of leverage relative to market capitalization visualizes this resilience, where the value of 0.20 characterizes this level. Business efficiency is based on royalties from patent licensing, which minimizes logistics costs and optimizes operating expenses, maintaining liquidity at normative levels.

TherapeuticsMD, Inc. (TXMD) specializes in the commercialization of innovative hormone therapy for women. By analyzing the debt-to-capitalization ratio on GURU.Markets, an investor assesses the proportion of borrowed funds relative to the total asset value. This metric determines the stability of the financing structure and the default risk during long-term planning. A low ratio minimizes the threat of write-downs but may indicate conservative growth. Debt balance is critically important for scaling marketing efforts and pharmacy partnerships.